Spelling suggestions: "subject:"catenin"" "subject:"katenin""
221 |
Activation de la phosphatase PTP SHP2 par le système de l'adrénomédulline dans les cellules endothéliales en vue d'une stabilisation vasculaire / Phosphatase PTP-SHP2 activation by the adrenomedullin system in vascular endothelial cells allowing tumor vessels stabilizationSigaud, Romain 20 December 2017 (has links)
L’adrénomédulline (AM) est un des principaux facteurs de croissance impliqués dans la formations de nouveaux vaisseaux. L’AM est responsable de la formation de jonctions adhérentes stables entre cellules endothéliales vasculaires via le maintien d’un état déphosphorylé du complexe d’adhésion VE-cadhérine/caténines. La phosphorylation de tyrosines est un évènement régulé par un équilibre entre protéine tyrosine kinases et protéine tyrosine phosphatases (PTP). Peu de choses sont encore connues sur le rôle des PTPs dans les voies de signalisation de l’AM au niveau des cellules endothéliales. La SHP2 a été décrite comme étant capable de déphosphoryler le complexe d’adhésion. Son association avec la β-caténine lui permet de contrôler le niveau de phosphorylation du complexe et de maintenir l’association entre VE-cadhérine et caténines. Nous avons ainsi émis l’hypothèse selon laquelle l’AM puisse agir sur la SHP2 permettant ainsi le contrôle de la formation du complexe d’adhésion VE-cadhérine-β-caténine. Nos travaux ont mis en évidence une augmentation de l’activation de la SHP2 induite par l’AM dans les cellules endothéliales entrainant sa localisation au niveau de la membrane et la stabilisation de l'adhésion cellulaire induite par la VE-cadhérine en réduisant le niveau de phosphorylation de cette dernière. Le blocage de la SHP2 entraine des effets opposés avec une inhibition de la déphosphorylation induite par l’AM de la VE-cadhérine sur les tyrosines 731 et 658. En résumé, l’AM régule l’activité de la SHP2 via sa phosphorylation sur la tyrosine 542 ce qui entraine une stabilisation des contacts cellules-cellules via une diminution de la phosphorylation de la VE-cadhérine. / Adrenomedullin (AM) is one of the main factors in the formation of tumor neo-vessels. It's responsible for stable adherent junction formation between vascular endothelial (VE) cells by maintaining VE-cadherin/catenins adhesion complex in a dephosphorylated status. Indeed, AM blockade induces phosphorylation of VE-cadherin in tyrosine 731, which is followed by disruption of VE-cadherin-mediated cell-cell contacts of endothelial cells (ECs), thereby leading to EC adhesion loss and tumor vessels disruption. Tyrosine phosphorylation events are controlled by the balance of activation of protein tyrosine kinases and protein tyrosine phosphatases (PTPs). Little is known about the role of endogenous PTPs in AM signaling in ECs. SHP2 is capable of dephosphorylating the complex. Its association with β-catenin allows it to control the dephosphorylated steady state of the complex and to maintain the VE-cadherin/β-catenin association. To study the mechanism of AM on the inter-endothelial junction stabilization, we hypothesized that AM may act on SHP2 allowing a control upon formation of VE-cadherin-β-catenin complex. In this study, we found that SHP2 activity is markedly increased by AM. In ECs, AM-induced phospho-SHP2 Y542 activity to localize at the human umbilical vein endothelial cell membrane and stabilizes VE-cadherin-mediated cell-cell adhesions by reducing VE-cadherin tyrosine phosphorylation. SHP2 inhibition causes opposite effects with inhibiting AM-induced dephosphorylation of VE-cadherin at Y731 and Y658. In summary, AM regulates SHP2 activity through phosphorylation of Y542, which stabilizes cell-cell adhesions through reducing tyrosine phosphorylation of VE-cadherin.
|
222 |
Altera??es nos genes da E-caderina e ?-catenina em adenoma pleom?rfico e carcinoma aden?ide c?stico: estudo molecular e imuno-histoqu?mico / Alterations of E-cadherin and ?-catenin genes in pleomorphic adenoma and adenoid cystic carcinoma: molecular and immunohistochemical studyCavalcante, Roberta Barroso 30 August 2008 (has links)
Made available in DSpace on 2014-12-17T15:32:27Z (GMT). No. of bitstreams: 1
RobertaBC.pdf: 1065704 bytes, checksum: 6e6f9aa3d97c1150d7b5fd4167469597 (MD5)
Previous issue date: 2008-08-30 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico / Pleomorphic adenoma and adenoid cystic carcinoma represent a benign and malignant salivary gland neoplasm, respectively, that shares the same histological origin, however with distinct biological behavior. The aim of the present study was identify the -160 C/A
polymorphism in the gene CDH1, mutational analysis of CTNNB1 gene and evaluation the expression of the E-cadherin and ?-catenin in pleomorphic adenomas and adenoid cystic carcinomas. Furthermore, it was proposed correlate the immunochemistry staining patterns with the polymorphism and mutations. Twenty-four pleomorphic adenomas and 24 adenoid
cystic carcinomas were retrieved. The polymorphism analysis was performed by restriction fragment length polymorphism (RFLP), using the restriction enzymes HphI or AflIII and the mutational screening was performed by PCR-single strand conformational polymorphism
(PCR-SSCP). The immunohistochemical analysis was taken by the counting of cells, recorded as the Hscore index, and considering the presence or absence, intensity, distribution and localization of proteins expression. Comparing the two neoplasms, the results demonstrated statistically significant difference for the E-cadherin and ?-catenin expression, with pleomorphic adenoma presenting weaker immunostaining. Was observed statistical correlation between E-cadherin and ?-catenin expression. CDH1 heterozigotic polymorphism was seen in two cases and 13 cases displayed abnormal mobility electrophoretic shifts, suggesting CTNNB1 gene mutation. The immunohistochemical expression was not statistically correlated with the polymorphism or suggested mutations. In conclusion this study supports that the E-cadherin/?-catenin complex immunohistochemical expression might be related with the myoepithelial component amount and differentiation neither the tumor biological behavior. The cases that showed E-cadherin gene polymorphism presented
reduced protein expression and, moreover, CTNNB1 suggested mutations seem not influence in the ?-catenin protein expression / O adenoma pleom?rfico e o carcinoma aden?ide c?stico representam neoplasias de gl?ndula salivar benigna e maligna, respectivamente, que compartilham a mesma origem histol?gica, por?m com comportamentos biol?gicos distintos. O prop?sito deste estudo consistiu na identifica??o do polimorfismo -160 C/A da regi?o promotora do gene CDH1 (E-caderina), na triagem de muta??es no gene CTNNB1 (?-catenina), e ainda na an?lise da express?o imuno-histoqu?mica das prote?nas E-caderina e ?-catenina em adenomas pleom?rficos e carcinomas aden?ides c?sticos. Al?m disso, objetivou-se correlacionar os achados imuno-histoqu?micos com
as poss?veis muta??es e polimorfismo. Foram selecionados 24 casos de adenoma pleom?rfico e 24
casos de carcinoma aden?ide c?stico. Para a identifica??o do polimorfismo no gene da E-caderina empregou-se a t?cnica RFLP (restriction fragment length polymorphism) utilizando-se enzimas de restri??o HphI e AflIII. A triagem de muta??es no exon 3 do gene da ?-catenina foi realizada por meio de SSCP (single strand conformational polymorphism). Para a an?lise imuno-histoqu?mica,
procedeu-se contagem de c?lulas, por meio do ?ndice HScore e verificou-se presen?a ou aus?ncia, intensidade, padr?o de distribui??o e localiza??o celular e tecidual das prote?nas. Os resultados demonstraram diferen?a estatisticamente significativa quando a marca??o imuno-histoqu?mica, tanto da E-caderina quanto ?-catenina, foi comparada entre as duas neoplasias estudadas, apresentando o adenoma pleom?rfico express?o reduzida. Observou-se correla??o estatisticamente significativa entre a imuno-marca??o da E-caderina e ?-catenina. Dois casos (1 adenoma pleom?rfico e 1 carcinoma aden?ide c?stico) apresentaram polimorfismo heterozig?tico no gene CDH1 e 13 casos (6 adenomas pleom?rficos e 7 carcinomas aden?ides c?sticos) exibiram varia??o no padr?o de corrida eletrofor?tica, sugerindo muta??o do gene CTNNB1. N?o houve
correla??o estatisticamente significativa entre a marca??o imuno-histoqu?mica e presen?a de polimorfismo ou poss?veis muta??es. Conclui-se que a express?o imuno-histoqu?mica do complexo E-caderina/?-catenina pode estar relacionada com a quantidade e diferencia??o do componente mioepitelial e n?o ao comportamento biol?gico dos tumores. Os casos que exibiram polimorfismo no gene da E-caderina apresentaram redu??o na express?o prot?ica e, por fim, as poss?veis muta??es no gene CTNNB1 parecem n?o influenciar na express?o da prote?na ?-catenina
|
223 |
Express?o imuno-histoqu?mica da e-caderina e da ?-catenina em carcinoma epiderm?ide oral com e sem met?stase nodalLopes, Fernanda Ferreira 28 September 2007 (has links)
Made available in DSpace on 2014-12-17T15:32:33Z (GMT). No. of bitstreams: 1
FernandaFL.pdf: 1297057 bytes, checksum: 8488c96c7464744f8dcbec706cd89a77 (MD5)
Previous issue date: 2007-09-28 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior / The adhesion molecules E-cadherin and β-catenin have been studied as possible markers to distinguish carcinomas with and without metastatic potential. The objective of this research was to study the imunohistochemistry expression of the E-cadherin and β-catenin in oral squamous cell carcinoma (OSCC), aiming to contribute for the better understanding of the biological behavior of this lesion. The sample consisted of 30 cases of OSCC, being 15 of tongue and 15 of lower lip. The profile and intensity of labeling and semi quantitative analysis of the percentage of immunopositive tumoral cells in membrane for E-cadherin and β-catenin had been related with the anatomical localization of the lesion, the presence or not of nodal metastasis and the histological grade of malignancy in the invasive front area of the tumor. It was registered the presence or not of cytoplasmic and nuclear labeling of the β-catenin. The results had been submitted to the statistical analysis, being used the Mann-Whitney Test, the Fisher Test and the Spearman Correlation Coefficient (α=0, 05). The results showed that the expression in membrane for E-cadherin and β-catenin was, predominantly, the heterogeneous profile in the lower lip and tongue carcinomas, as well as in the cases with and without nodal metastasis. It was not observed significant statistical difference between expression profile and amount of immunopositive cells for E-cadherin, β-catenin and the anatomical localization of the lesion and for the presence or not of nodal metastasis. However, there was significant difference of the reduced expression of these proteins with the high score of malignancy. It was verified that the expression of the β-catenin in cytoplasm was present in 22 (73.33%) of the 30 analyzed cases, and 6 cases (20%) showed nuclear expression. The statistical analysis detected significant association between the expression of the β-catenin in the cytoplasm with the histological grade of malignancy, being this molecule more frequently present in the cytoplasm in the cases of high score of malignancy. It was concluded that the reduced immunoexpression of these proteins in membrane can be related with the lowest cellular differentiation, as well as with the pattern of invasion in nests and isolated cells, demonstrated in the cases of OSCC with high histological grade of malignancy / As mol?culas de ades?o E-caderina e β-catenina t?m sido estudadas como poss?veis marcadores para distinguir carcinomas com e sem potencial metast?tico. O objetivo desta pesquisa foi estudar a express?o imuno-histoqu?mica da E-caderina e β-catenina em carcinoma epiderm?ide oral (CEO), visando contribuir para uma melhor compreens?o do comportamento biol?gico desta les?o. A amostra constou de 30 casos de CEO, sendo 15 de l?ngua e 15 de l?bio inferior. O padr?o e intensidade de marca??o e a an?lise semiquantitativa do percentual de c?lulas tumorais imunopositivas em membrana para E-caderina e β-catenina foram relacionados com a localiza??o anat?mica da les?o, a presen?a ou n?o de met?stase nodal e a grada??o histol?gica de malignidade no front de invas?o tumoral. Tamb?m foi registrada a presen?a ou n?o de imunomarca??o citoplasm?tica e nuclear da β-catenina. Os resultados foram submetidos ? an?lise estat?stica, sendo utilizados o Teste de Mann-Whitney, o Teste Exato de Fisher e o Coeficiente de correla??o de Spearman (α=0,05). Os resultados mostraram que a express?o em membrana para E-caderina e β-catenina exibiram, predominantemente, o padr?o heterog?neo nos carcinomas de l?bio inferior e nos de l?ngua, assim como nos casos com e sem met?stase nodal. Aplicados os testes estat?sticos, observou-se que n?o houve diferen?a significativa entre o padr?o de express?o e a quantidade de c?lulas imunopositivas para E-caderina e β-catenina e a localiza??o anat?mica da les?o e para a presen?a ou n?o de met?stase nodal. Por?m, verificou-se diferen?a estatisticamente significativa da express?o reduzida destas prote?nas com o alto escore de malignidade. Observou-se que a express?o da β-catenina em citoplasma estava presente em 22 (73,33%) dos 30 casos analisados, sendo que em 6 casos (20%) houve a express?o em n?cleo. Ap?s a an?lise estat?stica, foi detectada uma associa??o significativa entre a express?o da β-catenina no citoplasma com a grada??o histol?gica de malignidade, estando esta mol?cula mais freq?entemente presente no citoplasma nos casos de alto escore de malignidade. Conclui-se que a imunoexpress?o reduzida destas prote?nas em membrana pode estar relacionada com o menor grau de diferencia??o celular, bem como com o padr?o de invas?o em ninhos e em c?lulas isoladas, demonstrados nos casos de CEO de alto escore
|
224 |
Expressão de proteínas de adesão (e-caderina e β - catenina) e proliferação celular (ki-67) no fronte de invasão tumoral de Carcinomas Espinocelular e Escamoso Basalóide / Expression of adhesion proteins (e-cadherin and β-catenin) and cell proliferation (ki-67) at the invasive tumor front in coventional oral Squamous Cell and Basaloid Squamous Cell CarcinomasPereira, Carlos Henrique 07 July 2014 (has links)
Submitted by Luciana Ferreira (lucgeral@gmail.com) on 2016-01-29T08:31:16Z
No. of bitstreams: 2
Dissertação - Carlos Henrique Pereira - 2014.pdf: 3850945 bytes, checksum: 985b041e7a863070b3fa0562180a40f3 (MD5)
license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) / Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2016-01-29T08:33:08Z (GMT) No. of bitstreams: 2
Dissertação - Carlos Henrique Pereira - 2014.pdf: 3850945 bytes, checksum: 985b041e7a863070b3fa0562180a40f3 (MD5)
license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) / Made available in DSpace on 2016-01-29T08:33:08Z (GMT). No. of bitstreams: 2
Dissertação - Carlos Henrique Pereira - 2014.pdf: 3850945 bytes, checksum: 985b041e7a863070b3fa0562180a40f3 (MD5)
license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)
Previous issue date: 2014-07-07 / Fundação de Amparo à Pesquisa do Estado de Goiás - FAPEG / Objective: Investigate, on a comparative basis, the expression of the adhesion molecules E-cadherin (E-cad), β-catenin (β-cat) and the proliferation index (Ki-67) at the invasive tumor front (ITF) in Squamous Cell Carcinoma (SCC) and basaloid squamous cell carcinoma (BSCC).
Material and Methods: Thirty-five SCC and 16 BSCC cases were evaluated by immunohistochemistry. Clinico-pathological data and survival data were evaluated and compared.
Results: There was a low expression of E-cad in the cytoplasmic membrane (p = 0.50) as well as in the nucleus (p = 0.31) for both SCC and BSCC. A high expression of E-cad was seen in the cytoplasm for the SCC group (80%) when compared to the BSCC group (25%) (p<0.01). The expression of β-cat in the cytoplasmic membrane (p = 0.28) and in the cytoplasm (p = 0.44) was low in both SCC and BSCC groups. Both types of carcinoma presented low expressions of β-cat in the nucleus (p = 0.03). The Ki-67 expression was low irrespective of tumor variant. The high expression of E-cad in the cytoplasm was associated with T3/T4 tumors (p = 0.04) in the SCC group and there was no significant association of E-cad, β-cat, Ki-67 with the other clinical variables. In terms of disease-free survival and overall survival, there were no significant differences between SCC and BSCC.
Conclusion: The E-cad-β-cat system was found to be dysregulated in both oral SCC and oral BSCC. The Ki-67 cell proliferation index was extremely low in the cases investigated and consequently had no prognostic value. / Objetivo: Investigar comparativamente a expressão das moléculas de adesão E-caderina (E-cad), β-catenina (β-cat) e o índice de proliferação (Ki-67) em Carcinoma Espinocelular (CEC) e Carcinoma escamoso basalóide (CEB).
Material e Métodos: Nesse estudo, foram selecionados 35 casos de CEC e 16 casos de CEB e investigados por meio de técnica imuno-histoquímica. A associação das variáveis clinico-patológicas e dados de sobrevida foram avaliados.
Resultados: Ambos os grupos tiveram baixa expressão de E-cad em membrana citoplasmática (p=0,50) e núcleo (p=0,31), essa associação não foi estatisticamente significante entre os grupos. Alta expressão de E-cad no citoplasma foi notada no grupo CEC (80%) quando comparado ao grupo CEB (25%), p<0,01. A expressão de β-cat em membrana citoplasmática (p=0,28) e citoplasma (p=0,44) foram baixos em CEC e CEB. Ambos os grupos tiveram baixa expressão de β-cat em núcleo, p=0,03. Não houve diferença estatisticamente significante quanto à expressão de Ki-67 entre os grupos. Alta expressão de E-cad em citoplasma foi associada a tumores T3/T4 (p=0,04) no grupo CEC. Pacientes estilistas apresentaram baixa expressão de β-cat em membrana citoplasmática (p=0,05). Não houve associação entre a expressão de E-cad, β-cat e Ki-67 com as demais variáveis clínicas dos grupos. A sobrevida livre de doença e a sobrevida global não foram estatisticamente significantes na associação entre os grupos CEC e CEB.
Conclusão: O sistema E-cad-β-cat encontra-se desregulado tanto nos de CEC quanto nos de CEB de cavidade oral, levando as células epiteliais a perderem o seu fenótipo e promovendo a invasão e progressão tumoral. O índice de Ki-67 foi extremamente baixo não tendo valor prognóstico nos casos avaliados.
|
225 |
Envolvimento da Beta-catenina na via Wnt em meduloblastomas: estudo molecular e imunohistoquímico / Involvement of b-catenin gene in WNT pathway in medulloblastoma: molecular and immunohistochemical analysisRoseli da Silva 25 July 2007 (has links)
Meduloblastoma é um tumor embrionário maligno e invasivo do cerebelo, com manifestação preferencial em crianças, sendo predominantemente de diferenciação neuronal e tendência natural a metastatização por via liquórica. O gene da b-catenina (CTNNB1) está localizado no cromossomo 3p22-p21-3, sendo seu produto uma proteína citoplasmática de 92 kDa, envolvida na adesão celular e na transdução de sinal durante a embriogênese e morfogênese tecidual. A fosforilação da b-catenina é necessária para sua degradação, evitando a associação com o fator de transcrição Tcf (fator de célula T), responsável pela ativação de genes, cujos produtos promovem a proliferação celular. Estudos têm demonstrado a presença da b-catenina no núcleo das células de tumorais, um achado inesperado, pois, tratando-se de uma proteína envolvida na adesão celular, sua expressão seria esperada na membrana celular. Subseqüentemente foram descritas mutações no exon 3 do gene da b-catenina, envolvendo sítios de fosforilação. Este estudo teve como objetivo analisar em meduloblastomas: mutações no gene CTNNB1, o acúmulo da proteína b-catenina, bem como correlacionar ambos os achados entre si e com o tipo histológico e analisar os níveis de expressão relativa de genes envolvidos na via WNT (CTNNB1, AXIN1, WNT1 e APC) e correlaciona-los com o tipo histológico, idade e dados de mutação de CTNNB1 e acúmulo de b-catenina. As amostras de DNA foram extraídas de 67 casos de meduloblastomas. A análise de alterações no exon 3 de CTNNB1 foi realizada pela reação em cadeia da polimerase (PCR) e seqüenciamento direto. A expressão da b-catenina foi analisada pela técnica de imunohistoquímica (IHQ). As análises de expressão relativa de CTNNB1, AXIN1, WNT1 e APC foram realizadas pelo método de PCR quantitativo em tempo real (RQ-PCR) em 31 amostras de meduloblastomas. A freqüência de mutações do exon 3 de CTNBB1 foi de 15%. Foram identificadas 6 mutações missense e em heterozigose em 10 casos: troca de G por A (Asp32Asn) em um caso, troca de C por A (Ser34Tir) em quatro casos, troca de C por G (Ser33Cis) em dois casos, troca G por A (Gli34Arg) em um caso, troca de G por T (Gli34Glu) em um caso e troca de C por A (Ser37Tir) em um caso. Foi observada uma imunorreatividade de ß-catenina no núcleo em 36,4% dos casos analisados. No citoplasma, a ß-catenina estava presente em todos os casos. Não houve correlação entre o tipo histológico e os dados qualitativos e semi-quantitativos de IHQ. Também não houve correlação entre o tipo histológico com os achados de mutações. Não foi observada diferença nos níveis de expressão dos genes CTNNB1, AXIN1 e APC nos meduloblastomas em relação ao tecidos cerebelares não tumorais. Na análise de expressão relativa e a classificação histológica, apenas APC apresentou diferença entre o tipo clássico com o desmoplásico. Não houve diferença dos níveis de expressão relativa em nenhum dos genes com relação à idade do paciente. A presença de mutações de CTNNB1 não afetou a expressão relativa de CTNNB1 e APC. Por outro lado, AXIN1 apresentou uma maior expressão relativa nos casos com mutação. APC apresentou uma menor expressão quanto maior o acúmulo de b-catenina no núcleo. Os dados indicam que outras proteínas da via WNT podem estar envolvidas no acúmulo de b-catenina nas células de meduloblastomas, além do envolvimento de outras diferentes vias. / Medulloblastoma is a malignant invasive embryonal tumor of the cerebellum with a preferential manifestation in children, being predominantly with neuronal differentiation, and a natural tendency to metastasize through spinal fluid pathways. b-catenin gene (CTNNB1) is localized at chromosome 3p22-p21.3 and codifies a cytoplasmatic protein of 92 kDa, involved in cellular adhesion and signal transduction during embriogenesis and tissue morphogenesis. b-catenin phosphorylation is necessary for its degradation, avoiding association with Tcf (T cell factor), responsible for activation of some genes, whose products promote cellular proliferation. Studies have demonstrated the presence of b-catenin in the nucleus of tumoral cells, an unexpected finding because it is a protein involved in cellular adhesion and its normal localization is at the cellular membrane. Subsequentially, mutations in the phosphorylation sites, localized at the exon 3 of b-catenin gene, have been described. The aims of this study were to analyze in medulloblastomas: CTNNB1 gene mutations, the protein b-catenin accumulation, as well as to correlate both findings between them and with the histological type and to analyze the relative expression levels of genes involved in the WNT pathway (CTNNB1, AXIN1, WNT1 and APC). DNA samples were extracted from 67 cases of medulloblastoma. Alterations of CTNNB1 exon 3 were analyzed by polymerase chain reaction (PCR) and direct sequencing. The expression of the protein b-catenin was assessed by immunohistochemistry (IHC). The relative expression analyses of CTNNB1, AXIN1, WNT1 and APC were determined by quantitative real time PCR (RQ-PCR) in 31 medulloblastoma samples. The frequency of CTNBB1 exon 3 mutations in the CTNNB1 was 15%. We identified six missense heterozygous mutations in ten cases: a G to A change (Asp32Asn) in one case, a C to A change (Ser34Tyr) in four cases, a C to G change (Ser33Cys) in two cases, a G to A change (Gly34Arg) in one case and a G to T change (Gly34Glu) in one case and a C to A change (Ser37Tyr) in one case. It was observed b-catenin immunoreactivity in the nucleus in 36.4% of all cases analyzed. In the cytoplasm, the ß-catenin was present in all the cases. No correlation between histological type and IHQ qualitative and semi-quantitative. Also, there was no correlation between histological type and mutations. No difference in the expression levels of the genes CTNNB1, AXIN1 and APC were observed in medulloblastomas in relation to normal cerebellum samples by QT-PCR analysis. In the analysis of relative expression and the histological classification, only APC presented significant difference between classic and desmoplastic type. There was no difference of the relative expression levels of any gene with the patient?s age. The presence of CTNNB1 mutations did not affect the relative expression of CTNNB1 and APC. On the other hand, AXIN1 presented a higher relative expression in the cases with mutation. APC expression level was lower when b-catenin nuclear accumulation was higher. Our data indicate that other proteins of WNT pathway can be involved in b-catenin accumulation in medulloblastoma cells, as well as the involvement of other different pathways.
|
226 |
Possível ativação da via de sinalização Wnt/beta-catenina no processo de hiperplasia compensatória da célula beta pancreática em modelo animal de resistência periférica à insulina / Possible activation of the Wnt/beta-catenin signaling pathway in the compensatory hyperplasia of pancreatic beta cell in animal model of peripheral insulin resistanceMaschio, Daniela Aparecida, 1983- 24 August 2018 (has links)
Orientador: Carla Beatriz Collares Buzato / Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-24T14:09:15Z (GMT). No. of bitstreams: 1
Maschio_DanielaAparecida_M.pdf: 3472469 bytes, checksum: c4faacd3683560adfb7bc1ddb9464f73 (MD5)
Previous issue date: 2014 / Resumo: Tem havido um grande interesse na determinação das vias envolvidas na proliferação das células beta pancreáticas e a aplicação deste conhecimento em terapias moleculares e celulares da diabetes. Em especial, a via de sinalização da Wnt/beta-catenina (ou via Wnt canônica) tem sido pouco investigada no pâncreas endócrino. Em determinados tecidos/órgãos, é sabido que a proteína beta-catenina constitui não somente um componente estrutural das junções de adesão, mas também é uma molécula sinalizadora juntamente com a Wnt, participando de vários processos celulares, tais como diferenciação e proliferação. Hiperplasia da célula beta parece ocorrer em certas condições experimentais e in vivo, como no estado de resistência periférica à insulina. Entretanto, as vias intracelulares envolvidas nesse processo ainda permanecem desconhecidas. Os objetivos desta Dissertação de Mestrado foram: 1) verificar se as alterações metabólicas induzidas pela exposição à dieta hiperlipídica (DHL) por um curto período de tempo (60 dias) são acompanhadas por alterações morfométricas compensatórias do pâncreas endócrino de camundongos C57BL/6; 2) investigar o possível envolvimento da via de sinalização da Wnt/beta-catenina no processo de proliferação da célula beta neste modelo, analisando-se a localização celular (por imunofluorescência indireta), o conteúdo proteico (por immunoblotting) e a expressão gênica (por PCR de Tempo Real ou qPCR) de proteínas associadas à via Wnt/beta-catenina (a saber, beta-catenina, Ciclina D1/2, c-Myc, GSK-3? e Axina2 e, 3) analisar a expressão da proteína beta-catenina não fosforilada (forma ativa da via) em ilhotas não hiperplásicas de animais tratados com a DHL por apenas 30 dias. Nossos resultados demonstraram que, após 60 dias de tratamento com DHL, os animais se tornaram obesos e apresentaram acentuadas alterações metabólicas, tais como hiperglicemia em jejum e pós prandial, hiperinsulinemia em jejum e pós-prandial e, ainda, uma significativa resistência periférica à insulina (administrada intraperitonealmente), sendo esses animais, portanto, caracterizados como pré-diabéticos. Este quadro foi acompanhado por um aumento significativo da massa relativa de células beta e do seu número por ilhota, o que indica hiperplasia deste tipo celular no pâncreas endócrino, provavelmente compensatória ao quadro de resistência periférica à insulina apresentado pelos animais do grupo tratado. Como mostrado por immunoblotting, houve um aumento significativo na expressão de proteínas ativadoras ou alvo da via, como beta-catenina ativada (não fosforilada) e Ciclina D1/2 em ilhotas dos animais pré-diabéticos. Quanto às proteínas Axina2 e GSK-3? (inibidoras da via), não foi observada alteração significativa na expressão de Axina2, mas supreendemente houve aumento do conteúdo celular de GSK-3? nas ilhotas do grupo pré-diabético. A imunofluorescência para beta-catenina ativada mostrou a presença desta proteína tanto na região de contato intercelular como no citoplasma e núcleo das células beta para ambos os grupos. As outras três proteínas relacionadas à via, Ciclina D1/2, GSK-3? e Axina2, por sua vez, apresentaram uma distribuição exclusivamente citoplasmática nas células endócrinas das ilhotas pancreáticas, o que está de acordo com as suas respectivas funções. A análise por qPCR não revelou alteração significativa no conteúdo celular de RNAm de ?-catenina, mas uma tendência de aumento na expressão gênica de Ciclina D1 e c-Myc, genes alvo da via, em ilhotas hiperplásicas dos animais pré-diabéticos. Ainda, por immunoblotting para beta-catenina ativada, não observamos aumento significativo da expressão proteica dessa proteína em ilhotas do grupo tratado com DHL por apenas 30 dias, os quais não desenvolveram hiperplasia do pâncreas endócrino. Em conclusão, nossos dados sugerem que a via Wnt/beta-catenina parece estar ativada na pré-diabetes experimental, e provavelmente participa do processo de hiperplasia compensatória das células beta pancreática neste estado metabólico / Abstract: The role of the Wnt/beta-catenin signaling pathway (as known as the canonical Wnt pathway) in the endocrine pancreas physiology has not been thoroughly explored. In certain tissues/organs, it is known that beta-catenin, besides being a structural component of adhesion junctions, participates as a key protein in the Wnt signaling pathway, therefore being involved in crucial cellular processes such as differentiation and proliferation. Beta cell hyperplasia appears to occur under certain experimental conditions, and in vivo during the peripheral insulin resistance state. However, the intracellular pathways involved in this process are still unknown. The objectives of this Master's Dissertation were as follows: 1) to investigate whether the metabolic changes induced by exposure of adult male C57BL/6 mice to a high-fat diet (HFD) for a relatively short period of time (30 or 60 days) are accompanied by compensatory morphometric changes of the endocrine pancreas indicative of beta cell hyperplasia; and 2) to study the possible involvement of the pathway Wnt/?-catenin signaling in the process of beta cell proliferation in this animal model. For this, we carried out the analysis of the cellular localization (by indirect immunofluorescence), the protein cell content (by immunoblotting) and the gene expression (by PCR or Real-Time qPCR) of proteins associated to the Wnt/beta-catenin pathway (i.e., ?-catenin, Cyclin D1/2, c-Myc, Axin2 and GSK-3?). Our results showed that, after 60 days of treatment with HFD, the animals became obese, as well as, hyperglycemic, hyperinsulinemic (both at fast and fed states) and resistant to intraperitoneally injected insulin, being therefore characterized as prediabetic. This metabolic condition was accompanied by a significant increase in the relative mass of beta cells and the number of beta cells per islet, which indicates hyperplasia of this pancreatic endocrine cell, probably compensatory to the relatively higher insulin demand presented by the HFD-treated animals. As shown by immunoblotting, there was a significant increase in islet expression of the activator and target proteins, such as the active (unphosphorylated) beta-catenin and Cyclin D1/2 in prediabetic animals. Regarding Axina2 and GSK- 3? proteins (antagonists of the pathway), no changes were observed concerning Axin2 islet content between the experimental groups, but surprisingly there was a significant increase in cellular content of GSK-3? in islet homogenates from the prediabetic group. The immunofluorescence for active beta-catenin showed the presence of this protein at the intercellular contact region as well as within the cytoplasm and nucleus of beta cells in both groups. Meanwhile, Cyclin D1/2, GSK-3? and Axin2 displayed an exclusively cytoplasmic distribution in pancreatic endocrine cells, which is in accordance with their respective functions. The qPCR analysis revealed no significant change in mRNA expression of ?-catenin, but a tendency of increase in gene expression of Cyclin D1 and c-Myc, target genes of the pathway, in hyperplastic islets of the prediabetic animals. Additionally, the immunoblotting of active beta-catenin in homogenates of non-hyperplastic islets, isolated from mice fed a HFD for only 30 days, showed no significant change in expression this protein as compared to the control group. In conclusion, our data suggest that the Wnt/beta-catenin pathway may be activated during the process of compensatory hyperplasia of the beta cells seen in our animal model of obesity-associated prediabetes / Mestrado / Biologia Celular / Mestra em Biologia Celular e Estrutural
|
227 |
Effets phénotypiques de deux mécanismes d’activation de la voie Wnt/beta caténine dans le carcinome hépatocellulaire / Molecular phenotypes and clinical features associated with two types of Wnt/beta catenin activation in hepatocellular carcinomaDésert, Romain 16 December 2016 (has links)
Le carcinome hépatocellulaire (CHC) est une des principales causes de mortalité par cancer dans le monde. Dans environ 50% des tumeurs, on observe les signes d’une activation de la voie Wnt/β-caténine, causée par une mutation de l’exon 3 du gène CTNNB1 ou par stimulation du récepteur FRZD. Des études transcriptomiques du CHCs ont montré que ces deux modes d’activation étaient associés à des sous-types de tumeurs différents. Nous avons cherché à mieux comprendre les caractéristiques cliniques et le phénotype moléculaire de ces deux sous-types de CHCs. Dans un premier temps, nous avons fait le lien entre l'activation Wnt extracellulaire, un phénotype de cellules cancéreuses souches ou progénitrices et la présence de foyers de fibrose discrète intra-tumorale, observable par examen histopathologique, que nous avons appelés "nids fibreux". Nous avons également mis en évidence HAPLN1, une protéine de la matrice extracellulaire dont l’expression est stimulée par Wnt3a dans un modèle de cellules hépatiques progénitrices HepaRG, comme un nouveau marqueur d’agressivité du CHC. Ces résultats montrent une association entre l’activation Wnt extracellulaire et une agressivité tumorale passant par un remodelage matriciel. Dans un second temps, une Méta-analyse de données publiques de transcriptomique a permis de mettre évidence 4 sous-types de CHCs. La mutation CTNNB1, prédite par l’expression de 5 marqueurs par une méthode développée durant la thèse, était associée à un de ces sous-types et à un bon pronostic clinique. Nous avons également isolé un nouveau sous-type de CHC de bon pronostic exprimant un phénotype de tumeur différenciée et des signatures de métabolisme hépatique périportales. Ce sous-type a probablement été un facteur confondant dans les études précédentes mesurant l’association de la mutation CTNNB1 avec un bon pronostic. Enfin, nous avons mis en évidence une forte association négative entre la mutation CTNNB1 et l’inflammation ainsi que la fibrose tumorale dans trois cohortes indépendantes. Cet effet pourrait être provoqué par une inhibition de NF-κB par la β-caténine mutée, comme suggérée par des résultats préliminaires issue d’un modèle in vitro d’HepaRG mutés T41 stimulés par LPS. Nos résultats suggèrent donc que les deux modes d’activation de la voie Wnt/β-caténine sont associés à des mécanismes moléculaires, des profils d’expression, des phénotypes et des pronostics cliniques très différents. / Hepatocellular carcinoma (HCC) is the third cause of cancer-related death worldwide. Half of them show activation of Wnt/β-catenin pathway, caused by activating CTNNB1 exon 3 mutation of by stimulation of FRZD receptor. Transcriptomic based HCC classifications showed that this two types of activation were associated with distinct tumor subtypes. We tried to better understand the molecular phenotypes and the clinical features associated with these subtypes. In a first part, we linked extracellular Wnt activation with a stem/progenitor phenotype and with fibrous hotspot in HCC. Fibrous hotspot, which were called “fibrous nest”, can be detected by routine anatomic pathology analyses. We also showed that HAPLN1, an extracellular matrix protein induced by Wnt3a in progenitor HepaRG cells, was a new marker of stemness and bad outcome in HCC. Those results shows the associations between extracellular Wnt activation, extracellular matrix remodeling and tumor aggressiveness. In a second part, a transcriptome meta-analysis of 1133 HCCs highlighted 4 robust subclasses. CTNNB1 mutation, predicted by a 5-genes score based method, was associated with one of these subclasses and with good clinical features. We also highlighted a new subclass of CTNNB1 wild type HCCs associated with tumor differentiation, signatures of periportal metabolism and good outcome. This subclass was probably a confounding factor in survival studies comparing HCCs carrying mutant versus those carrying wild-type CTNNB1. Finally, we highlighted strong negative associations between CTNNB1 mutation and inflammation as well as tumor fibrosis in three independent cohorts. Preliminary results of in vitro HepaRG cells mutated for CTNNB1 in T41 and stimulated by LPS suggest an inhibitory effect of β-caténine on NF-κB. In conclusion, our results show that the two types of Wnt activation in HCC are associated with very distinct molecular phenotypes and clinical features.
|
228 |
Caractérisation de l'axe intégrine α5β1/protéine p53 dans les gliobastomes humains : application à une thérapie ciblée anti-tumorale / Characterization of the α5β1 integrin / p53 protein axis in human glioblastoma : application to a targeted anti-cancer therapyRenner, Guillaume 30 September 2016 (has links)
Les intégrines sont des protéines transmembranaires, formées d’une sous-unité α et d’une sous-unité β, qui sont impliquées dans de nombreuses caractéristiques du cancer. Mes travaux de thèses ont montré que l’axe intégrine α5β1/AKT est impliqué dans la résistance à l’apoptose des cellules de glioblastome et dans leur migration. L’inhibition fonctionnelle de l’intégrine α5β1 associée à la réactivation de p53 sensibilise les cellules de glioblastome à l’apoptose. Mes résultats ont mis en évidence que les protéines anti-apoptotiques PEA-15 et Survivine sont deux intervenants majeurs dans cette résistance à l’apoptose. La migration dépendante de l’intégrine α5β1 implique la β-caténine. Les résultats obtenus par ce travail de thèse, donnent, par conséquent, des arguments supplémentaires en faveur de l’implication de l’intégrine α5β1 dans l’agressivité des glioblastomes. Ces résultats permettent également de proposer de nouvelles cibles thérapeutiques ainsi que des biomarqueurs pertinents pour stratifier les patients potentiellement répondeurs à une stratégie anti-intégrine. / Integrins are αβ membrane localised protein heterodimers involved in numerous hallmarks of cancer. My PhD thesis showed that the integrin α5β1/AKT axis is implicated in glioblastoma cells resistance to apoptosis and migration. The inhibition of α5β1 integrin oncogenic pathway sensitizes glioma cells to p53-reactivation dependent apoptotic cues. My results showed that PEA-15 and Survivin are two anti-apoptotic proteins involved in the resistance to apoptosis. α5β1 integrin dependent migration involves the β-catenin pathway. My results confirm that α5β1 integrin has to be considered as an important player in glioblastoma aggressiveness and resistance to therapy. The results of my thesis also suggest new therapeutic targets and pertinent biomarkers for glioblastoma patient stratification.
|
229 |
Expression et fonction de l’adiponutrine/PNPLA3 dans le foie : Relation entre la voie Wnt/β-caténine, la sensibilité à l’insuline et la stéatose hépatique / Adiponutrin/PNPLA3 expression and function in mice liver : Cross-talk between Wnt/ β-catenin pathway, insulin sensitivity and hepatic steatosisDubuquoy, Céline 13 April 2012 (has links)
La prévalence du syndrome métabolique (MetS) est en constante augmentation dans les pays industrialisés. La stéatose hépatique, caractérisée par une accumulation massive de lipides dans les hépatocytes est une des manifestations du MetS. Parmi les SNP (Single Nucleotide Polymorphism) associés au MetS et à la stéatose hépatique, le SNP I148M de l’adiponutrine/PNPLA3 (Patatin-like Phospholipase Domain-Containing) est décrit comme un nouveau marqueur de la stéatose et également de la sévérité des différentes atteintes hépatiques des NAFLD (Non-alcoholic Fatty Liver diseases). L’objectif de ma thèse a été de déterminer le rôle de l’adiponutrine dans le foie, d’une part, en étudiant sa régulation transcriptionnelle par les facteurs de transcription SREBP1c (Sterol Responive Element Binding Protein) et ChREBP (Carbohydrate Responsive Element Binding Protein) en réponse à l’insuline et au glucose et d’autre part, en étudiant l’impact de sa surexpression sur le métabolisme glucido-lipidique dans le foie de souris. L’adiponutrine est régulée de façon semblable aux enzymes lipogéniques et semble avoir un impact sur le métabolisme lipidique dans le foie. Comme l’adiponutrine, différents SNP des médiateurs de la voie Wnt/β-caténine sont également associés au syndrome métabolique et au diabète. La voie Wnt/β-caténine joue un rôle déterminant dans la zonation du lobule hépatique. Nous nous sommes intéressés à la régulation de cette voie par les conditions nutritionnelles et dans un contexte physiopathologique de stéatose et de résistance à l’insuline. Nos résultats montrent la régulation de cette voie par les hormones pancréatiques (insuline et glucagon) dans le foie favorisant ainsi l’orientation métabolique des hépatocytes en fonction des besoins. De plus, cette voie est dérégulée dans le foie d’animaux résistants à l’insuline, suggérant qu’elle pourrait avoir une fonction dans ce désordre métabolique. / The prevalence of metabolic syndrome (MetS) has increased in industrial countries. The hallmark of MetS in the liver is an excessive accumulation of triglyceride, which is called hepatic steatosis. Different SNP (Single Nucleotide Polymorphism) are associated with hepatic steatosis or MetS. One of them is found on adiponutrin/PNPLA3 (Patatin-like Phospholipase Domain-Containing) gene (SNP I148M) and is now considered as a new marker of hepatic steatosis and severity of NAFLD (Non-alcoholic Fatty Liver diseases). In order to understand the physiological role of adiponutrin in the liver, we studied its transcriptional regulation by SREBP1c (Sterol Responive Element Binding Protein) and ChREBP (Carbohydrate Responsive Element Binding Protein), mediators of insulin and glucose respectively. Moreover, by overexpressing adiponutrin in mice liver, we investigated its role in hepatic carbohydrate and lipid metabolism. We showed that adiponutrin is regulated as lipogenic genes and could have a role lipid metabolism. As for adiponutrin I148M, different SNP are found on substrats of Wnt/β-catenin pathway, a major pathway controlling acinus zonation. We examined the regulation of this pathway by nutritionnal status and in a pathophysiological context of insulin resistance and steatosis. We showed that Wnt/β-catenin pathway is regulated by pancreatic hormones (insulin and glucagon) in the liver in order to adapt hepatocyte phenotype to energetic needs. Moreover, this pathway is dysregulated in insulin resistant mice liver. These data may suggest a link between Wnt/β-catenin pathway deregulation and hepatic metabolic disorders.
|
230 |
Wnt-11 signalling, its role in cardiogenesis and identification of Wnt/β-catenin pathway target genesRailo, A. (Antti) 30 March 2010 (has links)
Abstract
Wnt genes encode secreted signalling molecules that control embryonic development including organogenesis, while dysregulated Wnt signalling is connected to many diseases such as cancer. Specifically, Wnts control a number of cellular processes such as proliferation, adhesion, differentiation and aging. Many Wnt proteins activate the canonical β-catenin signalling pathway that regulates transcription of a still poorly characterized set of target genes. Wnts also transduce their signaling in cells via β-catenin-independent “non-canonical” pathways, which are not well understood. In this study, Wnt-11 signalling mechanisms in a mammalian model cell line and roles of Wnt-11 in heart development were analyzed in detail. In addition the aim was to identify new Wnt target genes by direct chromatin immunoprecipitation and Affymetrix GeneChip assays in the model cells exposed to Wnt-3a.
Our studies reveal that Wnt-11 signalling coordinates the activity of key cell signalling pathways, namely the canonical Wnt/β-catenin, the JNK/AP-1, the NF-κB and PI3K/Akt pathways in the CHO cells. Analysis of the Wnt-11-deficient embryos revealed a crucial role in heart organogenesis. Wnt-11 signalling coordinates cell interactions during assembly of the myocardial wall and Wnt-11 localizes the expression of N-cadherin and β-catenin to specific cellular domains in the embryonic ventricular cardiomyocytes. Collectively these studies reveal that the mammalian Wnt-11 behaves as a non-canonical Wnt and that it is a critical factor in the coordination of heart development. Specifically, it controls components of the cell adhesion machinery. Analysis of the Wnt target genes revealed a highly context-dependent profile in the Wnt-regulated genes. Several new putative target genes were discovered. Out of the candidate Wnt target genes, Disabled-2 was identified as a potential new direct target for Wnt signalling.
|
Page generated in 0.0606 seconds